Parenteral anticoagulant ingredient specific

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 8
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2016-03-31T01:00:12-04:00",
  "meta" : {
    "versionId" : "16",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "TJC EH Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: Anticoagulants acceptable for parenteral route use as independent ingredients for use in noting the most general idea of a parenteral anticoagulant medication. Initial use is for representation of a medication \"not done\". The desire is to have a single choice.),(Data Element Scope: Medication order or discharge, NOT DONE),(Inclusion Criteria: Only single ingredient, ingredient-level representation of parenteral anticoagulant medications.),(Exclusion Criteria: Anticoagulants not acceptable for parenteral route. Any form not a single ingredient type.)",
  "name" : "ParenteralAnticoagulantIngredientSpecific",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "15202",
      "display" : "argatroban",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "235473",
      "display" : "heparin, porcine",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "237057",
      "display" : "lepirudin",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "321208",
      "display" : "fondaparinux",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "60819",
      "display" : "bivalirudin",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "67108",
      "display" : "enoxaparin",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "67109",
      "display" : "dalteparin",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "69646",
      "display" : "tinzaparin",
      "version" : "04012024"
    } ],
    "total" : 8,
    "identifier" : "urn:uuid:5af39803-5fa0-40e7-bc2f-c43bf2a31c4a",
    "timestamp" : "2024-04-23T06:33:53-04:00"
  },
  "title" : "Parenteral anticoagulant ingredient specific",
  "extension" : [ {
    "valueString" : "TJC EH Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueString" : "Not_In_Use",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-keyWord"
  }, {
    "valueDate" : "2024-04-02",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2016-03-31",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "retired",
  "id" : "f9a0ae8d-ce71-429c-9fc5-edcbb601d956",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.4",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1021.4"
  } ],
  "version" : "20160331"
}